107 related articles for article (PubMed ID: 3170114)
1. Metastatic patterns in autopsy cases of cutaneous melanoma.
Akslen LA; Heuch I; Hartveit F
Invasion Metastasis; 1988; 8(4):193-204. PubMed ID: 3170114
[TBL] [Abstract][Full Text] [Related]
2. Patterned distribution of metastases from malignant melanoma in humans.
de la Monte SM; Moore GW; Hutchins GM
Cancer Res; 1983 Jul; 43(7):3427-33. PubMed ID: 6850649
[TBL] [Abstract][Full Text] [Related]
3. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.
Cook MG; Spatz A; Bröcker EB; Ruiter DJ
J Pathol; 2002 Jun; 197(2):188-93. PubMed ID: 12015742
[TBL] [Abstract][Full Text] [Related]
4. The natural course of cutaneous melanoma.
Leiter U; Meier F; Schittek B; Garbe C
J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923
[TBL] [Abstract][Full Text] [Related]
5. Metastatic distribution in malignant melanoma. A 30-year autopsy study.
Akslen LA; Hove LM; Hartveit F
Invasion Metastasis; 1987; 7(5):253-63. PubMed ID: 3679740
[TBL] [Abstract][Full Text] [Related]
6. [Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma].
Tejera-Vaquerizo A; Barrera-Vigo MV; Fernández-Canedo I; Blázquez-Sánchez N; Mendiola-Fernández M; Fernández-Orland A; Bosch-García R; de Troya-Martín M; Herrera-Ceballos E
Actas Dermosifiliogr; 2007 Oct; 98(8):531-8. PubMed ID: 17919427
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
8. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
[TBL] [Abstract][Full Text] [Related]
9. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
10. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma.
Cassarino DS; Cabral ES; Kartha RV; Swetter SM
Arch Dermatol; 2008 Jan; 144(1):49-56. PubMed ID: 18209168
[TBL] [Abstract][Full Text] [Related]
11. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
[TBL] [Abstract][Full Text] [Related]
12. Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis.
Alterman AL; Fornabaio DM; Stackpole CW
J Natl Cancer Inst; 1985 Oct; 75(4):691-702. PubMed ID: 3862901
[TBL] [Abstract][Full Text] [Related]
13. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases.
Bron LP; Traynor SJ; McNeil EB; O'Brien CJ
Laryngoscope; 2003 Jun; 113(6):1070-5. PubMed ID: 12782825
[TBL] [Abstract][Full Text] [Related]
14. Metastatic melanoma of unknown origin at autopsy.
Akslen LA; Hartveit F
Eur J Surg Oncol; 1988 Oct; 14(5):379-82. PubMed ID: 3181440
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
16. Influence of age on survival in childhood spitzoid melanomas.
Pol-Rodriquez M; Lee S; Silvers DN; Celebi JT
Cancer; 2007 Apr; 109(8):1579-83. PubMed ID: 17326059
[TBL] [Abstract][Full Text] [Related]
17. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
Richtig E; Ludwig R; Kerl H; Smolle J
Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
[TBL] [Abstract][Full Text] [Related]
18. [Is surgical therapy of distant metastases of malignant melanoma worthwhile?].
Göhl J; Meyer T; Haas C; Altendorf-Hofmann A; Hohenberger W
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():122-6. PubMed ID: 9101809
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
Väisänen A; Kallioinen M; Taskinen PJ; Turpeenniemi-Hujanen T
J Pathol; 1998 Sep; 186(1):51-8. PubMed ID: 9875140
[TBL] [Abstract][Full Text] [Related]
20. Metastatic melanoma in the eye and orbit.
Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
